Search

Your search keyword '"Vink, Geraldine R."' showing total 313 results
Start Over Author "Vink, Geraldine R."
313 results on '"Vink, Geraldine R."'

4. Towards patient-led follow-up after curative surgical resection of stage I, II and III colorectal cancer (DISTANCE-trial): a study protocol for a stepped-wedge cluster-randomised trial

Author

Swartjes, Hidde, Qaderi, Seyed M., Teerenstra, Steven, Custers, Jose A. E., Elferink, Marloes A. G., van Wely, Bob J., Burger, Jacobus W. A., van Grevenstein, Wilhelmina M. U., van Duijvendijk, Peter, Verdaasdonk, Emiel G. G., de Roos, Marnix A. J., Coupé, Veerle M. H., Vink, Geraldine R., Verhoef, Cornelis, and de Wilt, Johannes H. W.

Published
2023
Full Text
View/download PDF

6. Results from the UNITED study: a multicenter study validating the prognostic effect of the tumor–stroma ratio in colon cancer

Author

Petrushevska, Gordana, Bogdanovska, Magdalena, Zdravkoski, Panche, Antovic, Svetozar, Dzambaz, Darko, Karagjozov, Panche, de Cuba, Erienne M.V., Beverdam, Frédérique, Jansen, Jan, Vermaas, Maarten, Gašljević, Gorana, Kjær-Frifeldt, Sanne, Lindebjerg, Jan, Strous, Maud, Vogelaar, Jeroen F., Bulkmans, Nicole W.J., van Baarlen, Joop, Mekenkamp, Leonie, Hoekstra, Ronald, Sie, Mark, Cuatrecasas, Miriam, Simonetti, Sara, Rodrigo, María Teresa, Sanz, Iván Archilla, Guerrero Pineda, Jose, Leeuwis-Fedorovich, Natalja E., Talsma, Koen A., Souza da Silva, Ricella M., Lacle, Miangela M., Koopman, Miriam, Dekker, Jan Willem T., van Tilburg, Arjan, Nuciforo, Paolo, Villalobos Alberú, Xenia, Landolfi, Stefania, Zucchiatti, Adriana, Witteveen, Emma, Bordbar, Arad, Hendriks, Mathijs P., Arensman, René, Natu, Shonali, Maka, Noori, Mesker, Wilma E., Tollenaar, Rob A.E.M., Polack, Meaghan, Smit, Marloes A., van Pelt, Gabi W., Putter, Hein, Meershoek-Kleinenbarg, Elma, Roodvoets, Annet G.H., Crobach, Augustinus S.L.P., Gelderblom, Hans, Fontes e Sousa, Mário, Borralho Nunes, Paula, Cruz, João, Raimundo, Ana, Silva, Nelson, Brito, Maria J., Terpstra, Valeska, Zakhartseva, L.M., Al Dieri, Raed, Fléjou, Jean-François, Feakins, Roger, Dequeker, Els, Vink, Geraldine R., van Krieken, J.Han J.M., Polack, M., Smit, M.A., van Pelt, G.W., Roodvoets, A.G.H., Meershoek-Klein Kranenbarg, E., Putter, H., Gelderblom, H., Crobach, A.S.L.P., Terpstra, V., Petrushevska, G., Gašljević, G., Kjær-Frifeldt, S., de Cuba, E.M.V., Bulkmans, N.W.J., Vink, G.R., Al Dieri, R., Tollenaar, R.A.E.M., van Krieken, J.H.J.M., and Mesker, W.E.

Published
2024
Full Text
View/download PDF

7. The Assessment of Burden of ColoRectal Cancer (ABCRC)-tool; a validity and reliability study

Author

Thomassen, Britt J.M., Kimman, Merel L., Somers, Anne M.J., Ponds, Rudolf W.H.M., Dekker, Jan Willem T., van Leiden, Barbara L., Vink, Geraldine R., de Groot, Jan Willem B., Melenhorst, Jarno, Reynders, Kim M.M.W., Gielen, Christel M.J., Weerts, Tom H.A., Lutke Holzik, Martijn F., van Kuijk, Sander M.J., Breukink, Stéphanie O., and Gidding-Slok, Annerika H.M.

Published
2024
Full Text
View/download PDF

13. Quality of Life and Survival of Metastatic Colorectal Cancer Patients Treated With Trifluridine-Tipiracil (QUALITAS)

Author

Beerepoot, Laurens V., Creemers, Geert-Jan, van Cruijsen, Hester, de Groot, Jan Willem B., van Halteren, Henk K., Helgason, Helgi H., Hendriks, Mathijs P., Hoekstra, Ronald, van Huis-Tanja, Lieke H., Kapiteijn, Ellen, Los, Maartje, van Meerten, Esther, Peters, Natascha A.J.B., Pruijt, Johannes F.M., van Ufford-Mannesse, Patricia Quarles, Sie, Mark P.S., Sommeijer, Dirkje W., Spierings, Leontine E.A.M.M., Terheggen, Frederiek, Tjin-A-Ton, Manuel L.R., Valkenburg-van Iersel, Liselot B.J., van Voorthuizen, Theo, de Vos-Geelen, Judith, Vulink, Annelie J.E., J van de Wouw, Agnès, Hamers, Patricia A.H., Vink, Geraldine R., Elferink, Marloes A.G., Stellato, Rebecca K., Dijksterhuis, Willemieke P.M., Punt, Cornelis J.A., Koopman, Miriam, and May, Anne M.

Published
2022
Full Text
View/download PDF

14. Quality of life and functional outcome of rectal cancer patients: A prospective cohort study.

Author

Pennings, Alexander J., Vink, Geraldine R., Kuijk, Sander, Melenhorst, Jarno, Beets, Geerard L., May, Anne M., and Breukink, Stephanie O.

Subjects
*COLORECTAL cancer, *MINIMALLY invasive procedures, *CANCER prognosis, *FUNCTIONAL status, *MEDICAL screening
Abstract

Aim Methods Results Conclusion In the last decade, the Netherlands has implemented various diagnostic and treatment strategies to enhance rectal cancer outcomes. This study, using data from the Prospective Dutch ColoRectal Cancer (PLCRC) cohort, investigates whether these multidisciplinary advancements have translated into improved health‐related quality of life (HRQoL) and functional outcomes for the general Dutch rectal cancer population.Patients with Stage I–III rectal cancer enrolled in the PLCRC cohort were included. HRQoL and functional outcomes were assessed 1 and 2 years after diagnosis using the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ‐C30), EORTC QLQ Colorectal Cancer 29 and the Low Anterior Resection Syndrome score. HRQoL and functional outcomes were compared based on year of diagnosis (2014–2019).A total of 1294 patients were included. Two years after diagnosis, patients diagnosed in 2019 (n = 392) had a clinically relevant higher score on physical (8.2, 95% CI 4.1–12.3), role (13.5, 95% CI 7.3–19.7) and social functioning (5.8, 95% CI 0.3–11.2) compared to those diagnosed in 2014 (n = 65). Additionally, patients diagnosed in 2019 experienced less fatigue 2 years after diagnosis compared to those diagnosed in 2014 (−8.6, 95% CI −14.1 to −3.0). The Low Anterior Resection Syndrome score showed no differences.The findings of this study suggest that over the past decade rectal cancer patients in the Netherlands have witnessed improvements in HRQoL across various domains. Most probably, the improvement is due to a combination of implementation of population screening, a more restrictive neoadjuvant radiotherapy policy and advances in minimally invasive surgery and organ preserving treatment options. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

15. Colorectal cancer incidence, mortality, tumour characteristics, and treatment before and after introduction of the faecal immunochemical testing-based screening programme in the Netherlands: a population-based study

Author

van Bergeijk, Jeroen, Wiersma, Tjerk, van Grevenstein, Wilhelmina, Frasa, Marieke, van Gestel, Linda, Meijer, Gerrit, Breekveldt, Emilie C H, Lansdorp-Vogelaar, Iris, Toes-Zoutendijk, Esther, Spaander, Manon C W, van Vuuren, Anneke J, van Kemenade, Folkert J, Ramakers, Christian R B, Dekker, Evelien, Nagtegaal, Iris D, Krul, Myrtle F, Kok, Niels F M, Kuhlmann, Koert F D, Vink, Geraldine R, van Leerdam, Monique E, and Elferink, Marloes A G

Published
2022
Full Text
View/download PDF

16. Frailty and health related quality of life three months after non-metastatic colorectal cancer diagnosis in older patients: A multi-centre prospective observational study

Author

van der Vlies, Ellen, Vernooij, Lisette M., Hamaker, Marije E., van der Velden, Ankie M.T., Smits, Marianne, Intven, Martijn P.W., van Dodewaard, Joyce M., Takkenberg, Marijn, Vink, Geraldine R., Smits, Anke B., Bos, Willem Jan W., van Dongen, Eric P.A., Los, Maartje, and Noordzij, Peter G.

Published
2022
Full Text
View/download PDF

18. A consensus molecular subtypes classification strategy for clinical colorectal cancer tissues

Author

de Back, Tim R, primary, Wu, Tan, additional, Schafrat, Pascale JM, additional, ten Hoorn, Sanne, additional, Tan, Miaomiao, additional, He, Lingli, additional, van Hooff, Sander R, additional, Koster, Jan, additional, Nijman, Lisanne E, additional, Vink, Geraldine R, additional, Beumer, Inès J, additional, Elbers, Clara C, additional, Lenos, Kristiaan J, additional, Sommeijer, Dirkje W, additional, Wang, Xin, additional, and Vermeulen, Louis, additional

Published
2024
Full Text
View/download PDF

19. Results from the UNITED study: a multicenter study validating the prognostic effect of the tumor–stroma ratio in colon cancer

Author

Polack, M., primary, Smit, M.A., additional, van Pelt, G.W., additional, Roodvoets, A.G.H., additional, Meershoek-Klein Kranenbarg, E., additional, Putter, H., additional, Gelderblom, H., additional, Crobach, A.S.L.P., additional, Terpstra, V., additional, Petrushevska, G., additional, Gašljević, G., additional, Kjær-Frifeldt, S., additional, de Cuba, E.M.V., additional, Bulkmans, N.W.J., additional, Vink, G.R., additional, Al Dieri, R., additional, Tollenaar, R.A.E.M., additional, van Krieken, J.H.J.M., additional, Mesker, W.E., additional, Petrushevska, Gordana, additional, Bogdanovska, Magdalena, additional, Zdravkoski, Panche, additional, Antovic, Svetozar, additional, Dzambaz, Darko, additional, Karagjozov, Panche, additional, de Cuba, Erienne M.V., additional, Beverdam, Frédérique, additional, Jansen, Jan, additional, Vermaas, Maarten, additional, Gašljević, Gorana, additional, Kjær-Frifeldt, Sanne, additional, Lindebjerg, Jan, additional, Strous, Maud, additional, Vogelaar, Jeroen F., additional, Bulkmans, Nicole W.J., additional, van Baarlen, Joop, additional, Mekenkamp, Leonie, additional, Hoekstra, Ronald, additional, Sie, Mark, additional, Cuatrecasas, Miriam, additional, Simonetti, Sara, additional, Rodrigo, María Teresa, additional, Sanz, Iván Archilla, additional, Guerrero Pineda, Jose, additional, Leeuwis-Fedorovich, Natalja E., additional, Talsma, Koen A., additional, Souza da Silva, Ricella M., additional, Lacle, Miangela M., additional, Koopman, Miriam, additional, Dekker, Jan Willem T., additional, van Tilburg, Arjan, additional, Nuciforo, Paolo, additional, Villalobos Alberú, Xenia, additional, Landolfi, Stefania, additional, Zucchiatti, Adriana, additional, Witteveen, Emma, additional, Bordbar, Arad, additional, Hendriks, Mathijs P., additional, Arensman, René, additional, Natu, Shonali, additional, Maka, Noori, additional, Mesker, Wilma E., additional, Tollenaar, Rob A.E.M., additional, Polack, Meaghan, additional, Smit, Marloes A., additional, van Pelt, Gabi W., additional, Putter, Hein, additional, Meershoek-Kleinenbarg, Elma, additional, Roodvoets, Annet G.H., additional, Crobach, Augustinus S.L.P., additional, Gelderblom, Hans, additional, Fontes e Sousa, Mário, additional, Borralho Nunes, Paula, additional, Cruz, João, additional, Raimundo, Ana, additional, Silva, Nelson, additional, Brito, Maria J., additional, Terpstra, Valeska, additional, Zakhartseva, L.M., additional, Al Dieri, Raed, additional, Fléjou, Jean-François, additional, Feakins, Roger, additional, Dequeker, Els, additional, Vink, Geraldine R., additional, and van Krieken, J.Han J.M., additional

Published
2024
Full Text
View/download PDF

21. Harnessing the Potential of Real-World Evidence in the Treatment of Colorectal Cancer: Where Do We Stand?

Author

Onderzoek Medische Oncologie, Cancer, JC onderzoeksprogramma Kanker, MS Medische Oncologie, Epi Kanker Team B, Epi Kanker, van Nassau, Sietske C M W, Bol, Guus M, van der Baan, Frederieke H, Roodhart, Jeanine M L, Vink, Geraldine R, Punt, Cornelis J A, May, Anne M, Koopman, Miriam, Derksen, Jeroen W G, Onderzoek Medische Oncologie, Cancer, JC onderzoeksprogramma Kanker, MS Medische Oncologie, Epi Kanker Team B, Epi Kanker, van Nassau, Sietske C M W, Bol, Guus M, van der Baan, Frederieke H, Roodhart, Jeanine M L, Vink, Geraldine R, Punt, Cornelis J A, May, Anne M, Koopman, Miriam, and Derksen, Jeroen W G

Published
2024

22. Impact of colorectal cancer screening on survival after metachronous metastasis

Author

Cancer, Onderzoek Medische Oncologie, MS MDL 1, Epi Kanker Team B, Epi Kanker, JC onderzoeksprogramma Kanker, MS Medische Oncologie, Hamers, Patricia A H, Vink, Geraldine R, Elferink, Marloes A G, Moons, Leon M G, Punt, Cornelis J A, May, Anne M, Koopman, Miriam, Cancer, Onderzoek Medische Oncologie, MS MDL 1, Epi Kanker Team B, Epi Kanker, JC onderzoeksprogramma Kanker, MS Medische Oncologie, Hamers, Patricia A H, Vink, Geraldine R, Elferink, Marloes A G, Moons, Leon M G, Punt, Cornelis J A, May, Anne M, and Koopman, Miriam

Published
2024

24. Cumulative Incidence, Risk Factors, and Overall Survival of Disease Recurrence after Curative Resection of Stage II-III Colorectal Cancer: A Population-based Study

Author

Boute, Tara C., Swartjes, H., Greuter, Marjolein J.E., Elferink, Marloes A.G., Eekelen, R. van, Vink, Geraldine R., Wilt, J.H.W. de, Coupe, V.M.H., Boute, Tara C., Swartjes, H., Greuter, Marjolein J.E., Elferink, Marloes A.G., Eekelen, R. van, Vink, Geraldine R., Wilt, J.H.W. de, and Coupe, V.M.H.

Abstract

Contains fulltext : 305717.pdf (Publisher’s version ) (Open Access)

Published
2024

25. Early evaluation of the effectiveness and cost-effectiveness of ctDNA-guided selection for adjuvant chemotherapy in stage II colon cancer.

Author

Kramer, Astrid, Greuter, Marjolein J. E., Schraa, Suzanna J., Vink, Geraldine R., Phallen, Jillian, Velculescu, Victor E., Meijer, Gerrit A., van den Broek, Daan, Koopman, Miriam, Roodhart, Jeanine M. L., Fijneman, Remond J. A., Retèl, Valesca P., and Coupé, Veerle M. H.

Abstract

Background: Current patient selection for adjuvant chemotherapy (ACT) after curative surgery for stage II colon cancer (CC) is suboptimal, causing overtreatment of high-risk patients and undertreatment of low-risk patients. Postoperative circulating tumor DNA (ctDNA) could improve patient selection for ACT. Objectives: We conducted an early model-based evaluation of the (cost-)effectiveness of ctDNA-guided selection for ACT in stage II CC in the Netherlands to assess the conditions for cost-effective implementation. Methods: A validated Markov model, simulating 1000 stage II CC patients from diagnosis to death, was supplemented with ctDNA data. Five ACT selection strategies were evaluated: the current guideline (pT4, pMMR), ctDNA-only, and three strategies that combined ctDNA status with pT4 and pMMR status in different ways. For each strategy, the costs, life years, quality-adjusted life years (QALYs), recurrences, and CC deaths were estimated. Sensitivity analyses were performed to assess the impact of the costs of ctDNA testing, strategy adherence, ctDNA as a predictive biomarker, and ctDNA test performance. Results: Model predictions showed that compared to current guidelines, the ctDNA-only strategy was less effective (+2.2% recurrences, −0.016 QALYs), while the combination strategies were more effective (−3.6% recurrences, +0.038 QALYs). The combination strategies were not cost-effective, since the incremental cost-effectiveness ratio was €67,413 per QALY, exceeding the willingness-to-pay threshold of €50,000 per QALY. Sensitivity analyses showed that the combination strategies would be cost-effective if the ctDNA test costs were lower than €1500, or if ctDNA status was predictive of treatment response, or if the ctDNA test performance improved substantially. Conclusion: Adding ctDNA to current high-risk clinicopathological features (pT4 and pMMR) can improve patient selection for ACT and can also potentially be cost-effective. Future studies should investigate the predictive value of post-surgery ctDNA status to accurately evaluate the cost-effectiveness of ctDNA testing for ACT decisions in stage II CC. Plain language summary: Effectiveness and cost-effectiveness of circulating tumour DNA-guided selection for adjuvant chemotherapy in patients with stage II colon cancer Most patients with stage II colon cancer (CC) are cured by surgery. Therefore, guidelines recommend to only offer adjuvant chemotherapy to patients who have a tumor with high-risk features. However, current selection is suboptimal, leading to recurrence of cancer in 13% of low-risk patients and unnecessary administration of chemotherapy in some high-risk patients. Previous studies indicate that a biomarker, so-called circulating tumour DNA (ctDNA), could improve the selection of high-risk patients for adjuvant chemotherapy, as patients who have detectable ctDNA in their blood after surgery are likely to develop a recurrence. Despite its potential, implementation is still pending. Our study assessed the long-term effectiveness and costs associated with various ctDNA-guided strategies for selecting high-risk patients for adjuvant chemotherapy in stage II CC. We used an health-economic model to simulate a cohort of 1000 Dutch patients with stage II CC from diagnosis to death. Next, we compared the health outcomes and costs of the ctDNA-guided strategies to those when selection is based on the Dutch guideline. We found that a combination of the Dutch guideline and ctDNA was the most effective strategy, but not cost-effective. Additional analyses showed that ctDNA-guided selection were cost-effective if the costs of the ctDNA test were below 1500 euros, if the ctDNA test performed significantly better, or if patients with detectable ctDNA responded better to chemotherapy. Thus, while post-surgery ctDNA status is a good indicator for recurrence risk, specific criteria related to ctDNA test performance and costs, in addition to combining ctDNA with current high-risk features, should be met to achieve cost-effective implementation. Looking ahead, future studies should explore how patients with detectable ctDNA respond to chemotherapy for next assessments of the cost-effectiveness of ctDNA-guided strategies in selecting patients with stage II CC for adjuvant chemotherapy. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

41. Oncological outcomes of screen-detected and non-screen-detected T1 colorectal cancers

Author

van der Schee, Lisa, additional, Haasnoot, Krijn Jan Cornelis, additional, Elias, Sjoerd G., additional, Gijsbers, Kim, additional, Alderlieste, Y.A., additional, Backes, Yara, additional, van Berkel, Annemarie M., additional, Boersma, Femke, additional, ter Borg, F, additional, Breekveldt, Emilie C.H., additional, Kessels, Koen, additional, Koopman, Miriam, additional, Lansdorp-Vogelaar, Iris, additional, van Leerdam, Monique E, additional, Rasschaert, Gertjan, additional, Schreuder, Ramon Michel, additional, Schrauwen, R W.M., additional, Seerden, Tom C.J., additional, Spanier, Marcel B.W., additional, Terhaar sive Droste, Jochim S., additional, Toes-Zoutendijk, Esther, additional, Tuynman, Jurriaan, additional, Vink, Geraldine R., additional, de Vos tot Nederveen Cappel, Wouter H, additional, Vleggaar, Frank P., additional, Lacle, M.M, additional, and Moons, Leon MG, additional

Published
2024
Full Text
View/download PDF

42. A scenario‐drafting study to explore potential future implementation pathways of circulating tumor DNA testing in oncology

Author

Kramer, Astrid, primary, Rubio‐Alarcón, Carmen, additional, van den Broek, Daan, additional, Vessies, Daan C. L., additional, van `t Erve, Iris, additional, Meijer, Gerrit A., additional, Vink, Geraldine R., additional, Schuuring, Ed, additional, Fijneman, Remond J.A., additional, Coupé, Veerle M.H., additional, and Retèl, Valesca P., additional

Published
2023
Full Text
View/download PDF

44. Genome-wide cell-free DNA fragmentation in patients with cancer

Author

Cristiano, Stephen, Leal, Alessandro, Phallen, Jillian, Fiksel, Jacob, Adleff, Vilmos, Bruhm, Daniel C., Jensen, Sarah Østrup, Medina, Jamie E., Hruban, Carolyn, White, James R., Palsgrove, Doreen N., Niknafs, Noushin, Anagnostou, Valsamo, Forde, Patrick, Naidoo, Jarushka, Marrone, Kristen, Brahmer, Julie, Woodward, Brian D., Husain, Hatim, van Rooijen, Karlijn L., Ørntoft, Mai-Britt Worm, Madsen, Anders Husted, van de Velde, Cornelis J. H., Verheij, Marcel, Cats, Annemieke, Punt, Cornelis J. A., Vink, Geraldine R., van Grieken, Nicole C. T., Koopman, Miriam, Fijneman, Remond J. A., Johansen, Julia S., Nielsen, Hans Jørgen, Meijer, Gerrit A., Andersen, Claus Lindbjerg, Scharpf, Robert B., and Velculescu, Victor E.

Published
2019
Full Text
View/download PDF

45. Prognostic value of Lynch syndrome, BRAFV600E, and RAS mutational status in dMMR/MSI‐H metastatic colorectal cancer in a pooled analysis of Dutch and French cohorts

Author

Zwart, Koen, primary, van der Baan, Frederieke H., additional, Cohen, Romain, additional, Aparicio, Thomas, additional, de la Fouchardiére, Christelle, additional, Lecomte, Thierry, additional, Punt, Cornelis J. A., additional, Sefrioui, David, additional, Verheijden, Rik J., additional, Vink, Geraldine R., additional, Wensink, G. Emerens, additional, Zaanan, Aziz, additional, Koopman, Miriam, additional, Tougeron, David, additional, and Roodhart, Jeanine M. L., additional

Published
2023
Full Text
View/download PDF

47. Abstract 3358: PLCRC-PROVENC3: assessing the prognostic value of post-surgery liquid biopsy cell-free circulating tumor DNA in stage III colon cancer patients

Author

Rubio-Alarcon, Carmen, primary, Ketelaars, Steven L., additional, Franken, Ingrid A., additional, van Nassau, Sietske C., additional, van der Kruijssen, Dave E., additional, Schraa, Suzanna J., additional, Linders, Theodora C., additional, Diemen, Pien Delis-van, additional, Alkemade, Maartje, additional, Bolijn, Anne, additional, Tijssen, Marianne, additional, Lemmens, Margriet, additional, van Dongen, Miranda, additional, Lanfermeijer, Mirthe, additional, Broeks, Annegien, additional, Meiqari, Lana, additional, Bosch, Linda J., additional, Velculescu, Victor E., additional, Greer, Amy, additional, Angiuoli, Samuel V., additional, Georgiadis, Andrew, additional, Riley, David, additional, White, James R., additional, Greco, Christopher, additional, Cox, Liam, additional, Broek, Daan van den, additional, Punt, Cornelis J., additional, Coupé, Veerle M., additional, Koopman, Miriam, additional, Roodhart, Jeanine, additional, Meijer, Gerrit A., additional, Sausen, Mark, additional, Vink, Geraldine R., additional, and Fijneman, Remond J., additional

Published
2023
Full Text
View/download PDF

48. Abstract 3366: A machine learning approach to determine the cellular origin of variants in liquid biopsies

Author

Canzoniero, Jenna V., primary, Balan, Archana, additional, Phallen, Jillian, additional, Landon, Blair V., additional, Sivapalan, Lavanya, additional, Green, Benjamin, additional, Belcaid, Zineb, additional, Scott, Susan C., additional, Pereira, Gavin, additional, Lam, Vincent K., additional, Zaidi, Ali H., additional, Kelly, Ronan J., additional, Hann, Christine L., additional, Iams, Wade T., additional, Lovly, Christine M., additional, Forde, Patrick M., additional, Meijer, Gerrit A., additional, Vink, Geraldine R., additional, Fijneman, Remond J., additional, Group, The MEDOCC, additional, Velculescu, Victor E., additional, Scharpf, Robert B., additional, and Anagnostou, Valsamo, additional

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results